AAAAAA

   
Results: 1-25 | 26-50 | 51-73
Results: 1-25/73
SELECTION OF LOCAL THERAPY AFTER NEOADJUVANT CHEMOTHERAPY IN PATIENTSWITH STAGE IIIA,B BREAST-CANCER
Authors: DANFORTH DN ZUJEWSKI J OSHAUGHNESSY J RISEBERG D STEINBERG SM MCATEE N NOONE M CHOW C CHAUDHRY U LIPPMAN M JACOBSON J OKUNIEFF P COWAN KH
Citation: Dn. Danforth et al., SELECTION OF LOCAL THERAPY AFTER NEOADJUVANT CHEMOTHERAPY IN PATIENTSWITH STAGE IIIA,B BREAST-CANCER, Annals of surgical oncology, 5(2), 1998, pp. 150-158
EFFICACY OF MULTIPLE ADMINISTRATIONS OF A RECOMBINANT ADENOVIRUS EXPRESSING WILD-TYPE P53 IN AN IMMUNE-COMPETENT MOUSE-TUMOR MODEL
Authors: LI Z RAKKAR A KATAYOSE Y KIM M SHANMUGAM N SRIVASTAVA S MOUL JW MCLEOD DG COWAN KH SETH P
Citation: Z. Li et al., EFFICACY OF MULTIPLE ADMINISTRATIONS OF A RECOMBINANT ADENOVIRUS EXPRESSING WILD-TYPE P53 IN AN IMMUNE-COMPETENT MOUSE-TUMOR MODEL, Gene therapy, 5(5), 1998, pp. 605-613
POSTCHEMOTHERAPY AND CYTOKINE PRETREATED MARROW STROMAL CELL-LAYERS SUPPRESS HEMATOPOIESIS FROM NORMAL DONOR CD34(+) CELLS
Authors: SCHWARTZ GN WARREN MK ROTHWELL SW ZUJEWSKI J HALVERSON DC COWAN KH TOLCHER A OSHAUGHNESSY J GRESS RE
Citation: Gn. Schwartz et al., POSTCHEMOTHERAPY AND CYTOKINE PRETREATED MARROW STROMAL CELL-LAYERS SUPPRESS HEMATOPOIESIS FROM NORMAL DONOR CD34(+) CELLS, Bone marrow transplantation, 22(5), 1998, pp. 457-468
ROLE OF WILD-TYPE P53 IN THE ENHANCEMENT OF CAMPTOTHECIN CYTOTOXICITYAGAINST HUMAN PROSTATE TUMOR-CELLS
Authors: ARAH IN SONG KM SETH P COWAN KH SINHA BK
Citation: In. Arah et al., ROLE OF WILD-TYPE P53 IN THE ENHANCEMENT OF CAMPTOTHECIN CYTOTOXICITYAGAINST HUMAN PROSTATE TUMOR-CELLS, Anticancer research, 18(3A), 1998, pp. 1845-1849
A PHASE-I STUDY OF TOPOTECAN FOLLOWED SEQUENTIALLY BY DOXORUBICIN IN PATIENTS WITH ADVANCED MALIGNANCIES
Authors: TOLCHER AW OSHAUGHNESSY JA WEISS RB ZUJEWSKI J MYHAND RC SCHNEIDER E HAKIM F GRESS R GOLDSPIEL B NOONE MH BREWSTER LR GOSSARD MR COWAN KH
Citation: Aw. Tolcher et al., A PHASE-I STUDY OF TOPOTECAN FOLLOWED SEQUENTIALLY BY DOXORUBICIN IN PATIENTS WITH ADVANCED MALIGNANCIES, Clinical cancer research, 3(5), 1997, pp. 755-760
CANCER GENE-THERAPY USING A NOVEL ADENOASSOCIATED VIRUS VECTOR EXPRESSING HUMAN WILD-TYPE P53
Authors: QAZILBASH MH XIAO X SETH P COWAN KH WALSH CE
Citation: Mh. Qazilbash et al., CANCER GENE-THERAPY USING A NOVEL ADENOASSOCIATED VIRUS VECTOR EXPRESSING HUMAN WILD-TYPE P53, Gene therapy, 4(7), 1997, pp. 675-682
SENSITIZATION OF CISPLATINUM BY A RECOMBINANT ADENOVIRUS VECTOR EXPRESSING WILD-TYPE P53 GENE IN HUMAN OVARIAN CARCINOMAS
Authors: SONG KM LI ZW SETH P COWAN KH SINHA BK
Citation: Km. Song et al., SENSITIZATION OF CISPLATINUM BY A RECOMBINANT ADENOVIRUS VECTOR EXPRESSING WILD-TYPE P53 GENE IN HUMAN OVARIAN CARCINOMAS, Oncology research, 9(11-12), 1997, pp. 603-609
DRUG-RESISTANCE MARKERS - ARE THEY BAD OR GOOD
Authors: MORROW C COWAN KH
Citation: C. Morrow et Kh. Cowan, DRUG-RESISTANCE MARKERS - ARE THEY BAD OR GOOD, Annals of oncology, 8(4), 1997, pp. 314-315
REDUCED FOLATE CARRIER GENE (RFC1) EXPRESSION AND ANTIFOLATE RESISTANCE IN TRANSFECTED AND NONSELECTED CELL-LINES
Authors: MOSCOW JA CONNOLLY T MYERS TG CHENG CC PAULL K COWAN KH
Citation: Ja. Moscow et al., REDUCED FOLATE CARRIER GENE (RFC1) EXPRESSION AND ANTIFOLATE RESISTANCE IN TRANSFECTED AND NONSELECTED CELL-LINES, International journal of cancer, 72(1), 1997, pp. 184-190
PROMOTING APOPTOSIS - A NOVEL ACTIVITY ASSOCIATED WITH THE CYCLIN-DEPENDENT KINASE INHIBITOR P27
Authors: KATAYOSE Y KIM M RAKKAR ANS LI ZW COWAN KH SETH P
Citation: Y. Katayose et al., PROMOTING APOPTOSIS - A NOVEL ACTIVITY ASSOCIATED WITH THE CYCLIN-DEPENDENT KINASE INHIBITOR P27, Cancer research, 57(24), 1997, pp. 5441-5445
IMMUNOHISTOCHEMICAL EXPRESSION OF PI-CLASS GLUTATHIONE-S-TRANSFERASE IS DOWN-REGULATED IN ADENOCARCINOMA OF THE PROSTATE
Authors: MOSKALUK CA DURAY PH COWAN KH LINEHAN M MERINO MJ
Citation: Ca. Moskaluk et al., IMMUNOHISTOCHEMICAL EXPRESSION OF PI-CLASS GLUTATHIONE-S-TRANSFERASE IS DOWN-REGULATED IN ADENOCARCINOMA OF THE PROSTATE, Cancer, 79(8), 1997, pp. 1595-1599
INHIBITORY EFFECTS OF POSTCHEMOTHERAPY AND GM-CSF PRETREATED MARROW STROMAL CELL-LAYERS ON HEMATOPOIESIS FROM NORMAL DONOR CD34+ CELLS
Authors: SCHWARTZ GN ROTHWELL SW ZUJEWSKI J HALVERSON DC OSHAUGHNESSY J COWAN KH GRESS RE
Citation: Gn. Schwartz et al., INHIBITORY EFFECTS OF POSTCHEMOTHERAPY AND GM-CSF PRETREATED MARROW STROMAL CELL-LAYERS ON HEMATOPOIESIS FROM NORMAL DONOR CD34+ CELLS, Blood, 90(10), 1997, pp. 3509-3509
MOLECULAR MECHANISM OF ANTIFOLATE TRANSPORT-DEFICIENCY IN A METHOTREXATE-RESISTANT MOLT-3 HUMAN LEUKEMIA-CELL LINE
Authors: GONG MK YESS J CONNOLLY T IVY SP OHNUMA T COWAN KH MOSCOW JA
Citation: Mk. Gong et al., MOLECULAR MECHANISM OF ANTIFOLATE TRANSPORT-DEFICIENCY IN A METHOTREXATE-RESISTANT MOLT-3 HUMAN LEUKEMIA-CELL LINE, Blood, 89(7), 1997, pp. 2494-2499
UP-REGULATION OF DF3, IN ASSOCIATION WITH ICAM-1 AND MHC CLASS-II BY IFN-GAMMA IN SHORT-TERM HUMAN MAMMARY-CARCINOMA CELL-CULTURES
Authors: SGAGIAS MK NIERODA C YANNELLI JR COWAN KH DANFORTH DN
Citation: Mk. Sgagias et al., UP-REGULATION OF DF3, IN ASSOCIATION WITH ICAM-1 AND MHC CLASS-II BY IFN-GAMMA IN SHORT-TERM HUMAN MAMMARY-CARCINOMA CELL-CULTURES, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 11(3), 1996, pp. 177-185
INTERLEUKIN-6 ACTS AS A PARACRINE GROWTH-FACTOR IN HUMAN MAMMARY-CARCINOMA CELL-LINES
Authors: CHIU JJ SGAGIAS MK COWAN KH
Citation: Jj. Chiu et al., INTERLEUKIN-6 ACTS AS A PARACRINE GROWTH-FACTOR IN HUMAN MAMMARY-CARCINOMA CELL-LINES, Clinical cancer research, 2(1), 1996, pp. 215-221
CELL-CYCLE REGULATION OF BRCA1 MESSENGER-RNA IN HUMAN BREAST EPITHELIAL-CELLS
Authors: GUDAS JM LI T NGUYEN H JENSEN D RAUSCHER FJ COWAN KH
Citation: Jm. Gudas et al., CELL-CYCLE REGULATION OF BRCA1 MESSENGER-RNA IN HUMAN BREAST EPITHELIAL-CELLS, Cell growth & differentiation, 7(6), 1996, pp. 717-723
THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN GENE CONFERS DRUG-RESISTANCE IN HUMAN GASTRIC AND COLON CANCERS
Authors: TOMONAGA M OKA M NARASAKI F FUKUDA M NAKANO R TAKATANI H IKEDA K TERASHI K MATSUO I SODA H COWAN KH KOHNO S
Citation: M. Tomonaga et al., THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN GENE CONFERS DRUG-RESISTANCE IN HUMAN GASTRIC AND COLON CANCERS, Japanese journal of cancer research, 87(12), 1996, pp. 1263-1270
PHASE-I CROSSOVER STUDY OF PACLITAXEL WITH R-VERAPAMIL IN PATIENTS WITH METASTATIC BREAST-CANCER
Authors: TOLCHER AW COWAN KH SOLOMON D OGNIBENE F GOLDSPIEL B CHANG R NOONE MH DENICOFF AM BARNES CS GOSSARD MR FETSCH PA BERG SL BALIS FM VENZON DJ OSHAUGHNESSY JA
Citation: Aw. Tolcher et al., PHASE-I CROSSOVER STUDY OF PACLITAXEL WITH R-VERAPAMIL IN PATIENTS WITH METASTATIC BREAST-CANCER, Journal of clinical oncology, 14(4), 1996, pp. 1173-1184
PHASE I II STUDY OF 72-HOUR INFUSIONAL PACLITAXEL AND DOXORUBICIN WITH GRANULOCYTE-COLONY-STIMULATING FACTOR IN PATIENTS WITH METASTATIC BREAST-CANCER/
Authors: FISHERMAN JS COWAN KH NOONE M DENICOFF A BERG S POPLACK D BALIS F VENZON D MCCABE M GOLDSPIEL B CHOW C OGNIBENE FP OSHAUGHNESSY J
Citation: Js. Fisherman et al., PHASE I II STUDY OF 72-HOUR INFUSIONAL PACLITAXEL AND DOXORUBICIN WITH GRANULOCYTE-COLONY-STIMULATING FACTOR IN PATIENTS WITH METASTATIC BREAST-CANCER/, Journal of clinical oncology, 14(3), 1996, pp. 774-782
PHASE-I STUDY OF PACLITAXEL IN COMBINATION WITH CYCLOPHOSPHAMIDE AND GRANULOCYTE-COLONY-STIMULATING FACTOR IN METASTATIC BREAST-CANCER PATIENTS
Authors: TOLCHER AW COWAN KH NOONE MH DENICOFF AM KOHLER DR GOLDSPIEL BR BARNES CS MCCABE M GOSSARD MR ZUJEWSKI J OSHAUGHNESSY JA
Citation: Aw. Tolcher et al., PHASE-I STUDY OF PACLITAXEL IN COMBINATION WITH CYCLOPHOSPHAMIDE AND GRANULOCYTE-COLONY-STIMULATING FACTOR IN METASTATIC BREAST-CANCER PATIENTS, Journal of clinical oncology, 14(1), 1996, pp. 95-102
DRUG-RESISTANT BREAST-CANCER CELLS FREQUENTLY RETAIN EXPRESSION OF A FUNCTIONAL WILD-TYPE P53 PROTEIN
Authors: GUDAS JM NGUYEN H LI T SADZEWICZ L ROBEY R WOSIKOWKSI K COWAN KH
Citation: Jm. Gudas et al., DRUG-RESISTANT BREAST-CANCER CELLS FREQUENTLY RETAIN EXPRESSION OF A FUNCTIONAL WILD-TYPE P53 PROTEIN, Carcinogenesis, 17(7), 1996, pp. 1417-1427
FUNCTIONAL P-GLYCOPROTEIN (PGP) AND WILD-TYPE (WT) P53 ACTIVITY ARE NOT ASSOCIATED WITH RESPONSE TO CHEMOTHERAPY IN CHILDHOOD ACUTE MYELOGENOUS LEUKEMIA (AML)
Authors: IVY SP GUDAS JM TAYLOR B CHHABRA A LI T COWAN KH
Citation: Sp. Ivy et al., FUNCTIONAL P-GLYCOPROTEIN (PGP) AND WILD-TYPE (WT) P53 ACTIVITY ARE NOT ASSOCIATED WITH RESPONSE TO CHEMOTHERAPY IN CHILDHOOD ACUTE MYELOGENOUS LEUKEMIA (AML), Pediatric research, 39(4), 1996, pp. 923-923
EARLY SUPPRESSIVE EFFECTS OF CHEMOTHERAPY AND CYTOKINE TREATMENT ON COMMITTED VERSUS PRIMITIVE HEMATOPOIETIC PROGENITORS IN PATIENT BONE-MARROW
Authors: SCHWARTZ GN HAKIM F ZUJEWSKI J SZABO JM CEPADA R RISEBERG D WARREN MK MACKALL CL SETZER A NOONE M COWAN KH OSHAUGHNESSY J GRESS RE
Citation: Gn. Schwartz et al., EARLY SUPPRESSIVE EFFECTS OF CHEMOTHERAPY AND CYTOKINE TREATMENT ON COMMITTED VERSUS PRIMITIVE HEMATOPOIETIC PROGENITORS IN PATIENT BONE-MARROW, British Journal of Haematology, 92(3), 1996, pp. 537-547
PROSPECTIVE, RANDOMIZED TRIAL OF 5-FLUOROURACIL, LEUCOVORIN, DOXORUBICIN, AND CYCLOPHOSPHAMIDE CHEMOTHERAPY IN COMBINATION WITH THE INTERLEUKIN-3 GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) FUSION PROTEIN (PIXY321) VERSUS GM-CSF IN PATIENTS WITH ADVANCED BREAST-CANCER/
Authors: OSHAUGHNESSY JA TOLCHER A RISEBERG D VENZON D ZUJEWSKI J NOONE M GOSSARD M DANFORTH D JACOBSON J CHANG V GOLDSPIEL B KEEGAN P GIUSTI R COWAN KH
Citation: Ja. Oshaughnessy et al., PROSPECTIVE, RANDOMIZED TRIAL OF 5-FLUOROURACIL, LEUCOVORIN, DOXORUBICIN, AND CYCLOPHOSPHAMIDE CHEMOTHERAPY IN COMBINATION WITH THE INTERLEUKIN-3 GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) FUSION PROTEIN (PIXY321) VERSUS GM-CSF IN PATIENTS WITH ADVANCED BREAST-CANCER/, Blood, 87(6), 1996, pp. 2205-2211
INTESTINAL FOLATE TRANSPORT, IDENTIFICATION OF A CDNA INVOLVED IN FOLATE TRANSPORT AND THE FUNCTIONAL EXPRESSION AND DISTRIBUTION OF ITS MESSENGER-RNA
Authors: SAID HM NGUYEN TT DYER DL COWAN KH RUBIN SA
Citation: Hm. Said et al., INTESTINAL FOLATE TRANSPORT, IDENTIFICATION OF A CDNA INVOLVED IN FOLATE TRANSPORT AND THE FUNCTIONAL EXPRESSION AND DISTRIBUTION OF ITS MESSENGER-RNA, Biochimica et biophysica acta. Biomembranes, 1281(2), 1996, pp. 164-172
Risultati: 1-25 | 26-50 | 51-73